Achilles Therapeutics plc has announced the transfer of data and samples from its TRACERx Non-Small Cell Lung Cancer study and its Material Acquisition Platform (MAP) to AstraZeneca for a total ...
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a significant growth in short interest in the month of December.As of December 31st, there was short interest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback